Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

85.7%

6 terminated/withdrawn out of 7 trials

Success Rate

14.3%

-72.2% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

6 terminated

Enrollment Performance

Analytics

Phase 3

2(50.0%)

Phase 1

1(25.0%)

N/A

1(25.0%)

4Total

Phase 3(2)

Phase 1(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01614652Phase 3Terminated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Role: lead

NCT01286116Phase 3Terminated

A Multinational Trial To Evaluate The Parachute Implant System

Role: lead

NCT01297296Terminated

A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System

Role: lead

NCT02241837Terminated

PARACHUTE III Pressure Volume Loop Sub-Study

Role: lead

NCT02543632Terminated

PARACHUTE V PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE.

Role: lead

NCT00573560Phase 1Completed

Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients

Role: lead

NCT02240940Not ApplicableTerminated

PARACHUTE China Approval Trial

Role: lead

All 7 trials loaded